The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised




About SentreHEART

SentreHEART offers physicians precise control of remotely delivered suture for closure through developments in catheter technology and engineering expertise in remote suture delivery and tissue closure. The LARIAT Suture Delivery Device is indicated for suture placement and knot tying in surgical procedures where soft tissues are being approximated and/or ligated with a pre-tied polyester suture.

SentreHEART Headquarter Location

300 Saginaw Drive

Redwood City, California, 94063,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing SentreHEART

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned SentreHEART in 1 CB Insights research brief, most recently on Aug 14, 2019.

Expert Collections containing SentreHEART

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SentreHEART is included in 2 Expert Collections, including Medical Devices.


Medical Devices

11,001 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,900 items

SentreHEART Patents

SentreHEART has filed 47 patents.

The 3 most popular patent topics include:

  • Cardiac anatomy
  • Cardiac arrhythmia
  • Cardiac electrophysiology
patents chart

Application Date

Grant Date


Related Topics




Cardiac anatomy, Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Heart diseases


Application Date


Grant Date



Related Topics

Cardiac anatomy, Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Heart diseases



Latest SentreHEART News

Boston Scientific, SentreHEART Inc., Occlutech, Coherex MedicalInc., AtriCureInc. – Politics for you

Nov 12, 2021

The report of Zion Market Research About Global Atrial Appendage Occluder Market Atrial Appendage Occluders Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast for 2016-2024 is an indispensable guide to position your business in a highly competitive market landscape. The report is tailored to the needs of our client and their current presence […] The post Boston Scientific, SentreHEART Inc., Occlutech, Coherex MedicalInc., AtriCureInc. – Politics for you appeared first on Archyworldys.

  • When was SentreHEART founded?

    SentreHEART was founded in 2005.

  • Where is SentreHEART's headquarters?

    SentreHEART's headquarters is located at 300 Saginaw Drive, Redwood City.

  • What is SentreHEART's latest funding round?

    SentreHEART's latest funding round is Acquired.

  • How much did SentreHEART raise?

    SentreHEART raised a total of $69.02M.

  • Who are the investors of SentreHEART?

    Investors of SentreHEART include AtriCure, U.S. Venture Partners, Prospect Venture Partners, Vivo Capital, Deerfield Management and 3 more.

  • Who are SentreHEART's competitors?

    Competitors of SentreHEART include Cerapedics, Svelte Medical Systems, MedShape, Celonova Biosciences, Transcend Medical and 11 more.

You May Also Like

Cerapedics Logo

Cerapedics is a privately held medical device company focused on developing and commercializing osteobiologic products based on its anorganic bone mineral (ABM) and synthetic small peptide (P-15) technology platform for use in a wide variety of spine, trauma and orthopedic surgical procedures. i-FACTOR bone graft is a biologic bone graft that utilizes a synthetic small peptide as an attachment factor intended to stimulate the natural bone healing process resulting in safe, predictable bone formation at a fraction of the cost of growth factors.


NeuroTrax is a medical device and technology company.

Glevel Logo

GLevel is a seed stage partnership between Three Arch Partners and Incept which is a syndicate of medical device entrepreneurs and clinicians starting new opportunities in the medical device space.


Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.


synecor is a medical device developer


CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.